AURLUMYN
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Oct 2023)
What this means for you
This application is over — abandoned 23 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88850125
- Mark type
- Stylized text
- Filed
- 27 Mar 2020
- Published for opposition
- 28 Jul 2020
- Abandoned
- 23 Oct 2023
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of systematic sclerosis and related conditions
Owner
- Eicos Sciences, Inc., San Mateo, CA, US
- Eicos Sciences, Inc., West Conshohocken, PA, US
Prosecution history
- 23 Oct 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Oct 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Apr 2023 — SOU EXTENSION 5 GRANTED
- 22 Mar 2023 — SOU EXTENSION 5 FILED
- 03 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Mar 2023 — SOU TEAS EXTENSION RECEIVED
- 08 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Sept 2022 — SOU EXTENSION 4 GRANTED
- 06 Sept 2022 — SOU EXTENSION 4 FILED
- 06 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 09 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2022 — SOU EXTENSION 3 GRANTED
- 07 Mar 2022 — SOU EXTENSION 3 FILED
- 07 Mar 2022 — SOU TEAS EXTENSION RECEIVED